Dopamine Agonists
Research News and Information

Saturday, November 21, 2009

Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.

30 Oct 2009 Dopamine (DA) D2 receptor supersensitivity has been linked to an increase in the density of the D2 high-affinity state as measured in vitro. The two- affinity-state model of the D2 receptor predicts that the ex vivo specific binding of ... Read more...

The time course of dopamine transmission in the ventral tegmental area.

19 Oct 2009 Synaptic transmission mediated by G-protein coupled receptors (GPCR) is not generally thought to be point-to-point. To determine the extent over which dopamine signals in the midbrain, the present study examined the concentration and time course of ... Read more...

[Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review]

3 Oct 2009 The Cochrane analysis confirms some well-known facts: initial therapy with dopamine agonists (DA) delays the incidence of motor complications, but is associated with inferior motor control and a higher frequency of non-motor adverse events (AE) ... Read more...

Latest indexed articles for 'Dopamine Agonists'

These are the very latest articles for this heading:

• Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro. 30 Oct 2009
• The time course of dopamine transmission in the ventral tegmental area. 19 Oct 2009
• [Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review] 3 Oct 2009
• Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS. 29 Sep 2009
• [Treatment of pituitary adenomas] 25 Sep 2009
• Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia. 21 Sep 2009
• Exercise activates redox-sensitive transcription factors and restores renal D1 receptor function in old rats. 14 Sep 2009
• Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients. 30 Aug 2009
• In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. 30 Aug 2009
• Drug-induced compulsive behaviors: exceptions to the rule. 30 Aug 2009
• Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. 30 Aug 2009
• [Management of Parkinson's disease in 2009] 24 Aug 2009
• Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. 23 Aug 2009
• A reassessment of risks and benefits of dopamine agonists in Parkinson's disease. 22 Aug 2009
• Dopamine controls persistence of long-term memory storage. 19 Aug 2009
• An ultra-short dopamine pathway regulates basal ganglia output. 17 Aug 2009
• An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease. 16 Aug 2009
• Drug-induced fibrotic valvular heart disease. 13 Aug 2009
• Presynaptic action of neurotensin on dopamine release through inhibition of D(2) receptor function. 12 Aug 2009
• Dopaminergic modulation of olfactory bulb processing affects odor discrimination learning in rats. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Dopamine Agonists'

Definition: Drugs that bind to and activate dopamine receptors.

Registry Number: 0

Descriptor UI: D018491

Alternative terms: Dopamine Agonists; Agonists, Dopamine; Receptor Agonists, Dopamine; Dopamine Receptor Agonist; Agonist, Dopamine Receptor; Receptor Agonist, Dopamine; Dopamine Receptor Agonists; Dopaminergic Agonists; Agonists, Dopaminergic; Dopaminergic Agonist; Agonist, Dopaminergic; Agonists, Dopamine Receptor; Dopamine Agonist; Agonist, Dopamine;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.150.151; D27.505.696.577.150.151;

Online Note: use DOPAMINERGIC AGENTS to search DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS 1989-94

History Note: 95; DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94

Technical Notes: GEN or unspecified; prefer specifics; DF: DOPAMINE AGON or DOPAMINE AG